gastroesophageal junction adenocarcinoma
Showing 26 - 50 of 99
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- 5-Fluorouracil
- +4 more
-
Aachen, Germany
- +14 more
Sep 7, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +27 more
- Carboplatin
- +4 more
-
Anchorage, Alaska
- +469 more
Aug 24, 2022
Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,
Recruiting
- Solid Tumor
- +7 more
- BNT141
- +2 more
-
Duarte, California
- +10 more
Aug 23, 2022
Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States
Terminated
- Pancreatic Adenocarcinoma
- +13 more
- GB1275
- +2 more
-
San Francisco, California
- +7 more
Aug 17, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Bemarituzumab
- +2 more
-
Anchorage, Alaska
- +140 more
Aug 11, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- pembrolizumab
- +3 more
- (no location specified)
Jul 13, 2022
Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Trifluridine/Tipiracil
- +2 more
-
Amiens, France
- +20 more
Jul 26, 2022
Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)
Not yet recruiting
- Gastric Cancer
- +3 more
- Claudin 18.2 CAR-T
- (no location specified)
Jul 21, 2022
Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)
Recruiting
- Esophagogastric Tumors
- +9 more
-
Basking Ridge, New Jersey
- +6 more
Jul 8, 2022
Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations
Recruiting
- Esophageal Squamous Cell Carcinoma
- +3 more
- Routine care as per site standard
-
Multiple Locations, GermanyMultiple sites, Gemany
Jun 3, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- pembrolizumab
- paclitaxel
- (no location specified)
May 12, 2022
Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial (CT048 Autologous Injection (CT048))
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- CT048 Autologous Injection (CT048)
- (no location specified)
May 24, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Kashiwa (Regorafenib,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Regorafenib
- +3 more
-
Kashiwa, Chiba, JapanNational Cancer Center Hospital East
May 23, 2022
Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7 Trial in Phoenix,
Active, not recruiting
- Gastric Cardia Adenocarcinoma
- +7 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +1 more
May 12, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,
Not yet recruiting
- Gastric Cancer
- +5 more
- IMU-131
- +2 more
-
Woodville South, South Australia, AustraliaThe Queen Elizabeth Hospital
Apr 12, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)
Active, not recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Atezolizumab
- +4 more
-
Frankfurt, Germany
- +1 more
Apr 14, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2022
Gastric Tumors, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel)
Terminated
- Gastric Neoplasms
- Gastroesophageal Junction Adenocarcinoma
- Pembrolizumab
- Paclitaxel
-
Beijing, Beijing, China
- +35 more
Apr 1, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Kashiwa (Trastuzumab Deruxtecan (T-DXd))
Recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Trastuzumab Deruxtecan (T-DXd)
-
Kashiwa, Chiba, JapanNational Cancer Center Hospital East
Apr 5, 2022
The Tumor Microenvironment for Locally Advanced Resectable
Recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- non-intervention
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Mar 24, 2022